Reports on the finding that the tyrosine kinase inhibitor Gleevec, currently used to treat cancers such as chronic myeloid leukemia, can also function as an antiviral drug to treat poxvirus infections. Ability of Gleevec to block the egress of poxviruses such as vaccinia virus from infected cells; Morphogenesis of poxviruses in the cytoplasm of infected cells.